Question to the Department of Health and Social Care:
To ask Her Majesty’s Government whether they will ask general practitioners who prescribe antifungals to patients with Alzheimer's disease to notify the National Health Service of the results of that treatment, in the light of the article published online by <i>Nature </i>on 15 October regarding the infection of different brain regions with fungi in Alzheimer's.
The use of antifungal medication is not licensed for the treatment of patients with Alzheimer's disease. Consequently there would be no requirement for systematic monitoring of the use of these drugs.